Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug-Receptor Interactions01:29

Drug-Receptor Interactions

4.7K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
4.7K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

2.6K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
2.6K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

2.3K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.3K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport01:19

Drug Absorption Mechanism: Carrier-Mediated Membrane Transport

3.4K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
3.4K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

913
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
913

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LysePred: A Multiscale Convolutional Neural Network for Predicting Hemolytic Activity of Antimicrobial Peptides.

ACS synthetic biology·2026
Same author

An Interpretable Deep Learning Framework Leveraging RNA Foundation Model and Capsule Networks for Accurate Prediction of RNA 2'-O-Methylation Sites.

Journal of chemical information and modeling·2026
Same author

MPMFMol: Multitask Self-Supervised Pretraining with Multimodal Fine-Tuning for Molecular Property Prediction.

Journal of chemical information and modeling·2026
Same author

Quantum computing applications in drug discovery.

Briefings in bioinformatics·2026
Same author

Precision-Guarded Graph-Text Alignment for Universal Chemical Understanding.

Journal of chemical information and modeling·2026
Same author

HKD-CPI: high-order knowledge distillation enhanced inductive compound-protein interaction prediction.

Bioinformatics (Oxford, England)·2026
Same journal

AdaWGAN: Data Augmentation for Few-Shot HD-sEMG Gesture Recognition Using Single-Trial Data.

IEEE journal of biomedical and health informatics·2026
Same journal

NeuroBooster: a domain-informed self-supervised learning paradigm tailored for brain MRI analysis.

IEEE journal of biomedical and health informatics·2026
Same journal

Graph Convolutional Neural Network based Depression Detection using Brain Functional Connectivity Measures.

IEEE journal of biomedical and health informatics·2026
Same journal

Improving Multi-Sensor Non-Invasive Glucose Detection through AI: A Domain Generalization Approach.

IEEE journal of biomedical and health informatics·2026
Same journal

Unmixing the Neck: Accurate Jugular Venous Pulse Detection From Wearable PPG.

IEEE journal of biomedical and health informatics·2026
Same journal

AD-DAE: Alzheimer's Disease Progression Modeling with Unpaired Longitudinal MRI using Diffusion Auto-Encoders.

IEEE journal of biomedical and health informatics·2026
See all related articles

Related Experiment Video

Updated: May 21, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.4K

Multi-Modal Deep Representation Learning Accurately Identifies and Interprets Drug-Target Interactions.

Jiayue Hu, Yuhang Liu, Xiangxiang Zeng

    IEEE Journal of Biomedical and Health Informatics
    |March 20, 2025
    PubMed
    Summary
    This summary is machine-generated.

    UnitedDTA integrates multi-modal data for superior drug-target interaction prediction. This explainable deep learning model improves binding affinity prediction and offers insights into drug discovery.

    More Related Videos

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.1K
    Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
    10:21

    Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

    Published on: February 23, 2024

    2.3K

    Related Experiment Videos

    Last Updated: May 21, 2025

    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    18.4K
    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.1K
    Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
    10:21

    Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

    Published on: February 23, 2024

    2.3K

    Area of Science:

    • Computational Biology
    • Drug Discovery
    • Artificial Intelligence

    Background:

    • Current deep learning models struggle with multi-modal biomolecule data for drug-target interaction prediction.
    • Limited performance and generalization are observed in existing methods due to incomplete data integration.

    Purpose of the Study:

    • To develop a novel explainable deep learning framework, UnitedDTA, for enhanced drug-target affinity prediction.
    • To improve the integration of multi-modal biomolecule data (sequence, graphs, 3D structures).
    • To enhance prediction performance and generalization for novel drugs and targets.

    Main Methods:

    • UnitedDTA employs contrastive learning and cross-attention mechanisms for multi-modal data integration and alignment.
    • The framework learns unified discriminative representations from diverse data types.
    • Explainability is incorporated to identify key substructures influencing binding activity.

    Main Results:

    • UnitedDTA significantly outperforms state-of-the-art methods on benchmark datasets for drug-target affinity prediction.
    • The model demonstrates superior generalization ability, particularly for unseen drug-target pairs.
    • The framework provides interpretable insights into drug-target complex interactions.

    Conclusions:

    • UnitedDTA offers a powerful and explainable approach for multi-modal drug-target interaction prediction.
    • The learned representations show potential for broader applications in drug discovery, such as molecular property prediction.
    • This framework advances the prediction accuracy and interpretability in computational drug discovery.